{"a":[{"_":"China in Global Clinical Development: Why Early Inclusion Matters","$":{"href":"/sponsored/china-global-clinical-development-why-early-inclusion-matters","hreflang":"en"}}]}

Summary

Article discusses the strategic importance of including China early in global clinical development programs for biotechs. No specific companies, drugs, or catalysts are mentioned.